Table 1.

Sexual penetrating activity and function 12 months postoperatively

	Reference group (11-15 months median= 12.5) N = 28	Study group (11-17 months median = 13) N = 79
Sexually active with penetrating sex (all)	61% (17/28)	84% (66/79)
Sexually active with penetrating sex and normal erections	0% (0/17)	15% (10/66)
Sexually active with penetrating sex and erections with PDE-5 inhibitors	47% (8/17)	32% (21/66)
Sexually active with penetrating sex and erections with intrauretral gel or intracavernous injection of PGE1	53% (9/17)	53% (35/66)
Not having any penetrating sexual activity	39% (11/28)	16% (13/79)